Skip to main content
Premium Trial:

Request an Annual Quote

Discovery Partners Sells Over-Allotment on Sale of Celera Genomics Shares

NEW YORK, May 14 (GenomeWeb News) - Discovery Partners International announced today that it has taken in $5.1 million from an over-allotment option in a public offering of its common stock.


DPI said that 1,083,300 over-allotment shares were purchased at the price of $5 per share, following on a public offering of the 7,220,000 shares that Celera Genomics recently sold. The Applera unit announced on Wednesday that it had sold its DPI stock for $32 million.


SG Cowen was the lead manager and Merriman Curhan Ford and Roth Capital Partners were co-managers for the offering.


The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.